Ibnsina Pharma (EGX:ISPH)

Market Cap	11.59B
Revenue (ttm)	68.07B
Net Income (ttm)	633.24M
Shares Out	1.01B
EPS (ttm)	0.63
PE Ratio	18.31
Forward PE	8.72
Dividend	0.16 (1.39%)
Ex-Dividend Date	Oct 13, 2025

Volume	9,199,395
Average Volume	4,006,597
Open	11.06
Previous Close	11.06
Day's Range	11.06 - 11.60
52-Week Range	4.66 - 11.60
Beta	0.49
RSI	66.79
Earnings Date	Nov 11, 2025

About Ibnsina Pharma

Ibnsina Pharma operates as a pharmaceutical distributor in Egypt. The company offers pharmaceutical and cosmetics products to private and public-sector customers, including retail chains, independent pharmacies, wholesalers, hospitals, and healthcare institutions. It also provides warehousing and logistic services for its suppliers; marketing solutions; importation and packaging services; and market research and analysis services, as well as value added services. The company was founded in 2001 and is headquartered in El Obour City, Egypt.

• Industry: Drugs, Drug Proprietaries, and Druggists' Sundries
• Founded: 2001
• Employees: 5,500
• Stock Exchange: Egyptian Stock Exchange
• Ticker Symbol: ISPH

Financial Performance

In 2024, Ibnsina Pharma's revenue was 55.84 billion, an increase of 64.49% compared to the previous year's 33.95 billion. Earnings were 497.80 million, an increase of 187.51%.